SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s
IQVIA's subsidiary priced a €950 million offering of senior notes due 2033 with a 4.625% coupon to refinance existing debt. The offering demonstrates ...
Alphabet Inc. entered into an equity distribution agreement dated June 1, 2026, authorizing the issuance and sale of up to $40 billion in Class A comm...
Datavault AI executed a non-binding term sheet for a $2.0 billion dilutive structured financing that would value shares at $1.55-$2.00 per share, with...
FingerMotion and BlueFlare Energy Solutions entered into a memorandum of understanding to develop behind-the-meter AI compute infrastructure across Al...
LIXTE Biotechnology Holdings issued pre-funded warrants with an initial exercise date in June 2026 as part of a securities purchase agreement. The war...
T&T Power Group Inc., a Camber Energy subsidiary, is amalgamating with Simson-Maxwell Ltd. under Canadian corporate law to continue as a single entity...
Tempest Therapeutics appointed two independent directors, Drake Richey and John Yee, MD, MPH, to its Board of Directors effective June 4, 2026. The ap...
Apollo IG Core Replacement disclosed its net asset value composition with investments at fair value of $1.325B against a cost basis of $1.311B as of A...
B&G Foods priced a $475 million offering of 11.00% senior notes due 2031 through an underwriting group led by Barclays Capital. Proceeds will be used ...
Patterson-UTI Energy updated its 2021 Long-Term Incentive Plan with amendments through June 4, 2026, governing equity awards for directors, employees,...
Pershing Square Inc. reported total assets under management of $33.0 billion as of April 30, 2026, driven by new Pershing Square USA fund launch and H...
Core Natural Resources issued an investor presentation highlighting operations in rare earth elements and critical minerals extraction, while disclosi...
Applied Aerospace & Defense is conducting an initial public offering of 32.5 million shares with underwriters Morgan Stanley, Jefferies, BofA Securiti...
Bio Green Med Solution, Inc. entered into a business combination agreement with Future NRG Sdn. Bhd. and selling shareholders dated June 4, 2026. The ...
Biomerica is divesting a 6% stake in Diagnosis S.A., a Poland-based medical products company, through a securities purchase agreement with multiple bu...
CRISPR Therapeutics AG filed amended articles of association as Exhibit 3.1 to an 8-K filing, updating corporate governance documents. The filing is a...
TopBuild stockholders must elect by June 29, 2026 to receive either $505 cash or 20.2 QXO shares per share held. The merger combines QXO, North Americ...
Abacus Global Management, Inc. established a comprehensive equity incentive plan to attract and retain talent through stock options, restricted awards...
W&T Offshore's board approved Amendment No. 1 to its 2023 Incentive Compensation Plan, increasing the aggregate share issuance limit to 22 million sha...
Fate Therapeutics presented its corporate pipeline progress focusing on off-the-shelf cell therapy development with plans to commence Phase 2 studies....